Pennant Investors
Latest statistics and disclosures from Pennant Investors's latest quarterly 13F-HR filing:
- Top 5 stock holdings are AMZN, TDG, AR, MSFT, MU, and represent 58.38% of Pennant Investors's stock portfolio.
- Added to shares of these 10 stocks: SATS (+$31M), AAPL (+$27M), ENOV (+$25M), AR (+$6.4M), PRM (+$5.2M), FGEN, ARQT, ALT, FATE, NRIX.
- Started 33 new stock positions in IGMS, RLAY, Agenus, ALLO, SATS, AGIO, BTAI, CHRS, ALT, ENOV.
- Reduced shares in these 4 stocks: GOOGL (-$27M), , AMZN (-$9.4M), MSFT (-$7.2M).
- Sold out of its position in DISH Network.
- Pennant Investors was a net buyer of stock by $43M.
- Pennant Investors has $404M in assets under management (AUM), dropping by 45.82%.
- Central Index Key (CIK): 0001759176
Tip: Access up to 7 years of quarterly data
Positions held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Portfolio Holdings for Pennant Investors
Pennant Investors holds 44 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Amazon (AMZN) | 13.2 | $53M | -14% | 296k | 180.38 |
|
TransDigm Group Incorporated (TDG) | 12.8 | $52M | 42k | 1231.60 |
|
|
Antero Res Call Option (AR) | 11.7 | $47M | +15% | 1.6M | 29.00 |
|
Microsoft Corporation (MSFT) | 11.7 | $47M | -13% | 112k | 420.72 |
|
Micron Technology (MU) | 8.9 | $36M | 306k | 117.89 |
|
|
Echostar Corp Cl A (SATS) | 7.6 | $31M | NEW | 2.2M | 14.25 |
|
Alphabet Cap Stk Cl A (GOOGL) | 7.4 | $30M | -46% | 199k | 150.93 |
|
Apple Put Option (AAPL) | 6.8 | $27M | NEW | 160k | 171.48 |
|
Colfax Corp (ENOV) | 6.2 | $25M | NEW | 400k | 62.45 |
|
ODP Corp. (ODP) | 5.3 | $21M | 400k | 53.05 |
|
|
Perimeter Solutions Sa Common Stock (PRM) | 4.2 | $17M | +43% | 2.3M | 7.42 |
|
Fibrogen (FGEN) | 0.4 | $1.8M | NEW | 768k | 2.35 |
|
Arcutis Biotherapeutics (ARQT) | 0.4 | $1.7M | NEW | 171k | 9.91 |
|
Altimmune Com New (ALT) | 0.3 | $1.1M | NEW | 110k | 10.18 |
|
Fate Therapeutics (FATE) | 0.3 | $1.1M | NEW | 146k | 7.34 |
|
Nurix Therapeutics (NRIX) | 0.2 | $835k | NEW | 57k | 14.70 |
|
Macrogenics (MGNX) | 0.2 | $645k | NEW | 44k | 14.72 |
|
Igm Biosciences (IGMS) | 0.2 | $626k | NEW | 65k | 9.65 |
|
Enanta Pharmaceuticals (ENTA) | 0.2 | $613k | NEW | 35k | 17.46 |
|
Allogene Therapeutics (ALLO) | 0.1 | $574k | NEW | 128k | 4.47 |
|
89bio (ETNB) | 0.1 | $518k | NEW | 45k | 11.64 |
|
Zentalis Pharmaceuticals (ZNTL) | 0.1 | $511k | NEW | 32k | 15.76 |
|
Arcus Biosciences Incorporated (RCUS) | 0.1 | $448k | NEW | 24k | 18.88 |
|
Arcturus Therapeutics Hldg I (ARCT) | 0.1 | $442k | NEW | 13k | 33.77 |
|
Agios Pharmaceuticals (AGIO) | 0.1 | $442k | NEW | 15k | 29.24 |
|
Travere Therapeutics Note 2.500% 9/1 | 0.1 | $430k | NEW | 56k | 7.71 |
|
Getaround (GETR) | 0.1 | $414k | 1.3M | 0.31 |
|
|
Zymeworks Del (ZYME) | 0.1 | $407k | NEW | 39k | 10.52 |
|
Coherus Biosciences (CHRS) | 0.1 | $402k | NEW | 168k | 2.39 |
|
Compass Therapeutics (CMPX) | 0.1 | $394k | NEW | 199k | 1.98 |
|
Relay Therapeutics (RLAY) | 0.1 | $352k | NEW | 42k | 8.30 |
|
Erasca (ERAS) | 0.1 | $342k | NEW | 166k | 2.06 |
|
Sage Therapeutics (SAGE) | 0.1 | $328k | NEW | 18k | 18.74 |
|
Novavax Com New (NVAX) | 0.1 | $288k | NEW | 60k | 4.78 |
|
Agenus Com New | 0.1 | $272k | NEW | 470k | 0.58 |
|
Uniqure Nv SHS (QURE) | 0.1 | $252k | NEW | 49k | 5.20 |
|
Replimune Group (REPL) | 0.1 | $249k | NEW | 31k | 8.17 |
|
Bioxcel Therapeutics (BTAI) | 0.1 | $237k | NEW | 84k | 2.82 |
|
Allakos (ALLK) | 0.1 | $235k | NEW | 186k | 1.26 |
|
Seres Therapeutics (MCRB) | 0.1 | $226k | NEW | 292k | 0.77 |
|
Allovir (ALVR) | 0.0 | $163k | NEW | 216k | 0.75 |
|
Airspan Networks Holdings (MIMOQ) | 0.0 | $118k | 1.0M | 0.11 |
|
|
Bluebird Bio (BLUE) | 0.0 | $112k | NEW | 87k | 1.28 |
|
Grab Holdings *w Exp 99/99/999 (GRABW) | 0.0 | $16k | 80k | 0.20 |
|
Past Filings by Pennant Investors
SEC 13F filings are viewable for Pennant Investors going back to 2018
- Pennant Investors 2024 Q1 filed May 15, 2024
- Pennant Investors 2023 Q3 filed Nov. 14, 2023
- Pennant Investors 2023 Q2 filed Aug. 14, 2023
- Pennant Investors 2023 Q1 filed May 15, 2023
- Pennant Investors 2022 Q4 filed Feb. 14, 2023
- Pennant Investors 2022 Q3 filed Nov. 14, 2022
- Pennant Investors 2022 Q2 filed Aug. 15, 2022
- Pennant Investors 2022 Q1 filed May 16, 2022
- Pennant Investors 2021 Q4 filed Feb. 14, 2022
- Pennant Investors 2021 Q3 filed Nov. 15, 2021
- Pennant Investors 2021 Q2 filed Aug. 16, 2021
- Pennant Investors 2021 Q1 filed May 17, 2021
- Pennant Investors 2020 Q4 filed Feb. 16, 2021
- Pennant Investors 2020 Q3 filed Nov. 16, 2020
- Pennant Investors 2020 Q2 filed Aug. 14, 2020
- Pennant Investors 2020 Q1 filed May 15, 2020